Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439589
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-28
Brief Title:
Phase IbII Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
Sponsor:
Shanghai Hengrui Pharmaceutical Co Ltd
Organization:
Shanghai Hengrui Pharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumors |
Keywords: